Alemtuzumab reduces ms disease activity in active relapsing-remitting multiple sclerosis patients who had disease activity on prior therapy

Authors
Category Primary study
JournalNeurology
Year 2013
This article has no abstract
Epistemonikos ID: 43bbee8a2261214f88b57a50021ec5022eee1400
First added on: Feb 05, 2025